Worldwide, 12 million people suffer from autosomal-dominant polycystic kidney disease or ADPKD. In the U.S. the number is larger than those affected by Down syndrome, cystic fibrosis, muscular dystrophy and sickle cell anemia combined. UC Santa Barbara’s Dr. Thomas Weimbs, associate professor and director of the Weimbs Lab joined Levi and Tim this morning to discuss his team’s latest findings which could lead to one of the first drug treatments for a disease which currently can only be treated through dialysis and transplant.
